Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.51 |
| ▸ | MAPT | P10636 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3016187 | 0.85 | ALDH1A1 (0.49) | ALDH1A1MAPTKDM4ETSHRGAA | |
| SCHEMBL11225517 | 0.84 | TSHR (0.56) | ALDH1A1MAPTKDM4ETSHRGAA | |
| SCHEMBL11316665 | 0.83 | KDM4E (0.57) | ALDH1A1MAPTKDM4ETSHRGAA | |
| SCHEMBL28615622 | 0.83 | TSHR (0.55) | ALDH1A1MAPTKDM4ETSHRGAA | |
| SCHEMBL11404248 | 0.81 | KDM4E (0.56) | ALDH1A1MAPTKDM4ETSHRGAA | |
| SCHEMBL12013078 | 0.81 | TTR (0.50) | ALDH1A1MAPTGAASMN1; SMN2LMNA | |
| SCHEMBL12013081 | 0.81 | ALDH5A1 (0.51) | ALDH1A1MAPTSMN1; SMN2LMNA | |
| SCHEMBL13660659 | 0.81 | ALDH1A1 (0.46) | ALDH1A1MAPTGAALMNAL3MBTL1 | |
| SCHEMBL8798256 | 0.81 | TSHR (0.56) | ALDH1A1MAPTKDM4ETSHRGAA | |
| SCHEMBL11623299 | 0.80 | TSHR (0.51) | ALDH1A1MAPTKDM4ETSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827661-B2 | Water soluble fluorescent or colored dyes comprising conjugating groups | Sony Group Corporation (JP) | 2023-11-28 | — | — | US | disclosed |
| US-11685835-B2 | Ultra bright dimeric or polymeric dyes | SONY CORPORATION (JP) | 2023-06-27 | — | — | US | disclosed |
| US-20230129481-A1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | Sony Group Corporation (JP) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11827661-B2 | Water soluble fluorescent or colored dyes comprising conjugating groups | CHRM1, CHRM2, H1-0 | ALDH1A1 965/4885MAPT 16/4885KDM4E 4730/4885 |
| US-20230129481-A1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | IK, MTCL3, RRM1 | ALDH1A1 1336/4885MAPT 6/4885KDM4E 3783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.